Has-miR-875-5p Inhibits Tumorigenesis By Targeting USF2 Via TGF-β Signaling Pathway in Gastric Cancer

Shenshuo Gao(Shandong University), Xiaobo Guo(Shandong University), Xubin Wang(Shandong Provincial Hospital), Changqing Jing(Shandong Provincial Hospital), Chensheng Li(Sun Yat-sen University), Yan Ma(Shandong Provincial Hospital), Zhikai Zhang(Shandong Institute of Business and Technology), Hongjun Liu(Jiaxing University), Leping Li(Shandong University)
Research Square
November 1, 2021
10.21203/rs.3.rs-885737/v2
Cited by 0

Related Papers

Perioperative or postoperative adjuvant oxaliplatin with S-1 versus adjuvant oxaliplatin with capecitabine in patients with locally advanced gastric or gastro-oesophageal junction adenocarcinoma undergoing D2 gastrectomy (RESOLVE): an open-label, superiority and non-inferiority, phase 3 randomised controlled trial
|The Lancet Oncology|2021|436
The structure of the C‐terminal actin‐binding domain of talin
|The EMBO Journal|2007|205
Wnt Signaling Regulates Hepatic Metabolism
|Science Signaling|2011|172
Three-Dimensional Structure of Vinculin Bound to Actin Filaments
|Molecular Cell|2006|146
Comparison of sentinel lymph node biopsy guided by indocyanine green, blue dye, and their combination in breast cancer patients: a prospective cohort study
|World Journal of Surgical Oncology|2017|137